Toxoplasmosis in Cats: Zoonotic Risks, Clinical Signs, and Management

Etiology and Life Cycle

Toxoplasmosis is caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. Felids, particularly domestic cats (Felis catus), are the only definitive hosts in which the sexual phase of the parasite occurs [1, 2]. After a cat ingests tissue cysts from an infected intermediate host (e.g., rodents, birds), bradyzoites are released and invade enterocytes of the small intestine, initiating a complex developmental cascade involving merozoite production and gametogony [1, 2]. The formation of unsporulated oocysts that are shed in feces begins approximately 3–10 days post-infection and can continue for 1–3 weeks [3, 4]. Sporulation occurs outside the host and yields highly resistant sporulated oocysts that can survive in the environment for months to years [3, 4]. The pre-sexual stages of T. gondii have been characterized at the single-cell level, revealing distinct transcriptional programs that precede the formation of gametes [1, 2]. A comprehensive single-cell atlas of sexual development in the feline intestinal tract has further elucidated the spatial and temporal dynamics of these stages [2]. In addition, dynamic changes in microRNA expression within the feline small intestine have been documented during infection, suggesting regulatory roles in host-parasite interactions [5]. Non-feline animals, including goats [6, 7], cattle [8], pigs [9], deer [10], dogs [11], and wild felids [12], serve as intermediate hosts, harboring the rapidly dividing tachyzoite stage and subsequently forming latent tissue cysts. Molecular detection of T. gondii has been reported in an aborted equine fetus, confirming that other mammals can also serve as aberrant intermediate hosts [13]. Genotype distribution studies in Bangladesh have identified multiple clonal lineages circulating in domestic animals, indicating substantial genetic diversity [4].

Global Epidemiology in Cats

The seroprevalence of T. gondii in domestic cats varies widely by geographic region, management practices, and sampling methodology. A study in Hong Kong reported a seroprevalence of 16.7% in privately owned cats and 28.6% in community cats, with risk factors including age and outdoor access [14]. In Jordan, seroprevalence among cats was 42.1%, with PCR detection of T. gondii DNA in feces confirming active shedding in a subset of animals [3]. In urban informal settlements in Salvador, Brazil, seroprevalence in companion animals (including cats) reached 48.2%, with significant associations with environmental degradation and social marginalisation [15, 16]. Wild felids in Poland showed a seroprevalence of 38.5%, highlighting sylvatic cycles of transmission [12]. In contrast, intensive pig farms in eastern Spain reported a low seroprevalence in swine, partly attributable to controlled animal entry, but cats on those farms could still serve as environmental sources of oocysts [9]. Seroprevalence in cats in Bangkok, Thailand, as detected by PCR in fecal samples, was 11.2%, with stray cats showing higher positivity than owned animals [17]. Serological surveys in dogs in the Pantanal region of Brazil also showed high rates, indicating extensive environmental contamination with oocysts [11]. The AB blood group phenotype in cats does not appear to influence susceptibility to T. gondii infection, as no association was found between blood type and serostatus [18].

Zoonotic Risks and the Toxoplasmosis Cat Lady Disease Misconception

The term "toxoplasmosis cat lady disease" is a colloquial and often stigmatising phrase used to describe the misconception that cat ownership alone poses a major risk for acquiring toxoplasmosis. From a veterinary public health perspective, the primary risk of feline-to-human transmission is the accidental ingestion of sporulated oocysts shed in cat feces, typically via contaminated soil, water, or unwashed produce [15, 19]. Direct contact with an infected cat is not considered a high-risk activity because cats usually only shed oocysts for a short period and exhibit minimal fecal contamination of their fur [19]. However, certain groups, including pregnant women who are seronegative and immunocompromised individuals, are advised to take specific precautions [19]. Seroprevalence studies among veterinary medicine professionals in Aguascalientes, Mexico, indicated that occupational exposure to cats does not significantly increase infection risk, provided standard biosecurity measures are followed [20]. Pregnant women in Abidjan, Côte d'Ivoire, demonstrated low knowledge of toxoplasmosis prevention, highlighting the need for targeted education [21]. In quilombola communities, risk factors for seropositivity included consumption of raw meat and untreated water, with ocular health sequelae documented in some individuals [22]. Waterborne transmission has been linked to environmental contamination in Brazil [15]. In humans, T. gondii has been associated with various clinical outcomes, including cerebral toxoplasmosis in renal transplant recipients [23], ocular toxoplasmosis in adults [24], and potential links to psychotic experiences in children [25]. Seropositivity among patients with sickle cell disease has been associated with blood transfusion history, underscoring non-fecal routes of transmission [26]. A study in Kars, Turkey, found a significant association between anti-T. gondii antibody seropositivity and history of abortion or stillbirth in women [27]. The social misattribution of toxoplasmosis as a "cat lady disease" does not align with the epidemiological evidence, which shows that cat ownership without proper hygiene is a minor contributor compared to foodborne and environmental exposure [15, 20, 19].

Clinical Signs in Cats

Most T. gondii infections in cats are subclinical, but clinical disease can occur, particularly in kittens, immunocompromised adults, or with high-dose primary infection [28, 29]. The classic description of feline toxoplasmosis includes fever, lethargy, anorexia, and hepatomegaly. Respiratory signs such as dyspnea may arise from pulmonary involvement. Ocular manifestations include anterior uveitis, chorioretinitis, and panophthalmitis; the MIC17A antigen has been identified as a potential marker for both entero-epithelial and chronic stages, aiding in serological detection of active infection [28]. Neurological signs result from meningoencephalitis and may include ataxia, tremors, cranial nerve deficits, and seizures. In one study, T. gondii DNA was detected in reproductive tissues of cats enrolled in a neutering program, suggesting potential for vertical transmission or reproductive tract pathology [29]. Abortion and stillbirth have been documented in experimentally infected queens, and similar findings are reported in intermediate hosts such as goats [7] and mares [13]. Chronic infection is typically asymptomatic, with tissue cysts persisting in neural and muscular tissues for the life of the host.

Pathology

Histopathologically, acute toxoplasmosis in cats is characterized by focal necrotic lesions in the liver, lungs, spleen, pancreas, and central nervous system, associated with free tachyzoites and intracellular pseudocysts [1, 2]. In the intestine, sexual stages (meronts, gamonts, and oocysts) are observed in enterocytes during the patent period [1, 2]. Chronic lesions consist of well-formed tissue cysts (bradyzoites) surrounded by a minimal inflammatory response, primarily in the brain, skeletal muscle, and myocardium. Immunohistochemical staining or PCR can be used to confirm the presence of the parasite in formalin-fixed tissue [7]. In aborted caprine fetuses, myocarditis with intralesional tachyzoites has been demonstrated by both molecular and histopathological methods [7].

Diagnostics

Diagnosis of feline toxoplasmosis relies on a combination of serology, molecular detection, and antigen detection. Several commercial ELISA kits are available for serological screening. A double-antigen sandwich colloidal gold immunochromatographic strip has been developed and validated for detection of T. gondii antibodies across multiple host species, including cats [30]. Similarly, a SAG1-based colloidal gold strip offers a rapid, point-of-care option for serological detection in swine and could be adapted for feline use [31]. For detection of active infection or oocyst shedding, PCR assays targeting the B1 gene or the 529 bp repetitive element are widely applied to fecal samples [17, 3]. An antisense PCR assay has been developed and evaluated specifically for T. gondii detection in domestic cats, improving sensitivity by targeting complementary RNA transcripts [32]. The MIC17A protein has been explored as a serodiagnostic marker for entero-epithelial and chronic infections, potentially distinguishing recent from latent infection [28]. Real-time PCR can also be used for quantification of parasite burden in tissue specimens.

The following table summarizes the main diagnostic modalities and their advocated uses:

Treatment and Management

The cornerstone of antiprotozoal therapy for clinical feline toxoplasmosis is clindamycin, administered at 10–12 mg/kg orally every 12 hours for 2–4 weeks. Alternative or adjunctive therapies may include trimethoprim-sulfonamide combinations, pyrimethamine, or azithromycin, although treatment protocols are largely adapted from human medicine and experimental studies (Merck Veterinary Manual). In cases with ocular involvement, topical corticosteroids may be added to control inflammation after initiation of antiprotozoal therapy. Recent advances in vaccine development, including gene-edited live-attenuated strains and mRNA-based vaccines, represent a promising future direction for both feline and intermediate host populations [33, 34]. However, no licensed vaccine for toxoplasmosis in cats is currently commercially available. One Health strategies that integrate veterinary surveillance, animal management, and public education are essential for reducing the overall burden of T. gondii infection [34, 6].

The following Mermaid decision tree illustrates a clinical management algorithm for a cat presenting with suspected acute toxoplasmosis:

flowchart TD
    A[Cat with clinical signs suggestive of toxoplasmosis], > B{Serological testing}
    B, >|IgM positive or rising IgG| C[Confirm with PCR]
    B, >|Negative| D[Consider other diagnoses]
    C, >|PCR positive| E[Begin clindamycin therapy]
    C, >|PCR negative| F[Reassess clinical picture; consider ocular/histopathology]
    E, > G[Monitor clinical response]
    G, >|Improvement| H[Complete 4-week course]
    G, >|No improvement| I[Re-evaluate; consider alternative antiprotozoals]
    H, > J[Follow-up serology after 6 months]
    I, > J

Prevention and Control

Preventing T. gondii infection in cats and reducing zoonotic transmission require a multifactorial approach. Keeping cats indoors limits their access to infected intermediate hosts (rodents, birds) and reduces the likelihood of shedding oocysts [14, 3]. Litter boxes should be cleaned daily, because oocysts require at least 24–48 hours to sporulate and become infectious [3, 19]. Pregnant women and immunocompromised individuals should avoid handling cat litter; if unavoidable, wearing gloves and washing hands thoroughly is recommended [19]. Feeding cats only commercial cooked or canned food prevents ingestion of tissue cysts [14]. In agricultural settings, controlling feral cat populations and preventing cat access to livestock feed and water sources reduces contamination of the environment [15, 6, 16]. Public education campaigns targeting at-risk populations (e.g., pregnant women, university students) have been shown to improve knowledge and promote risk-reducing behaviors [21, 35]. The development of gene-edited vaccines for cats could one day provide a direct means of preventing oocyst shedding, thus breaking the transmission cycle [33, 34]. Integrated surveillance using molecular and serological tools in both domestic and wild felid populations is critical for tracking the effectiveness of control interventions [17, 12].

References

[1] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42153709/

[2] Alrubaye HS, Reilly SM, da Silva R et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020723/

[3] Alkhatatbeh SK, Lafi SQ, Hammad HB et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741047/

[4] Biswas PK, Aryal D, Tarak AN et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41528989/

[5] Zhai B, Bao B, Xie SC et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41965856/

[6] Muhammad AS, Kudi AC, Mohammed A et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42020619/

[7] Ait Issad N, Mohamed Cherif A, Mebkhout F et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864556/

[8] Hanedan B, Taş BZ, Yıldırım E et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41819961/

[9] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741032/

[10] Aziz KJ, Mikaeelb FB, Nasrullah OJ et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42034957/

[11] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41843222/

[12] Didkowska A, Kołodziej-Sobocińska M, Matusik K et al. Toxoplasma gondii in wild felides in Poland. BMC Vet Res. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41387866/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[13] Pinto GOA, Silva RAD, Oliveira PRF et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252005/

[14] Elsohaby I, Zubair M, Baqar Z et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42135800/

[15] Eyre MT, Wang JY, Carneiro IO et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42330015/

[16] Bazan L, Argibay HD, Borges-Silva W et al. Seroprevalence and risk factors for Toxoplasma gondii infection in wild, domestic and companion animals in urban informal settlements from Salvador, Brazil. PLoS Negl Trop Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41401226/

[17] Kengradomkij C, Chimnoi W, Kamyingkird K et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42094705/

[18] Spada E, Tattarletti G, Proverbio D et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41471183/

[19] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41628830/

[20] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42201205/

[21] Henriette BA, Jémima EK, Jean-Sébastien MA et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42199683/

[22] Filho SCC, Moron SE, Ferreira RG et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41597614/

[23] Mihaljević D, Sitaš Z, Hanulak J et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41900989/

[24] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41603939/

[25] Jesuthasan J, Merritt K, Solmi F et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41643571/

[26] Orish VN, Tetteh RE, Adzah D et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41931585/

[27] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42202767/

[28] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41874672/

[29] Murata FHA, Barboza JP, de Souza CAG et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41651631/

[30] Mu X, Chen C, Pu X et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253330/

[31] Chen XX, Sun H, Liang Y et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42169035/

[32] Li YY, Bai SY, Yu HQ et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41724116/

[33] Sang X, Zhang H, Zhang Y et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42252477/

[34] Qadeer A, Tharwat M, Khan MZ et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42188907/

[35] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41873025/